Galmed International, Ltd. Initiates Phase II Clinical Trial for Treatment of Fatty Liver Disease
10/14/2010 12:46:43 PM
More...
|
BioLineRx Ltd. In-Licenses Novel Technology From Galmed International, Ltd. For The Treatment Of Fatty Liver Disease; Innovative Small Molecule Has Potential For A One Billion Dollar Per Year Market
10/19/2005 5:13:00 PM
More...
|